216 related articles for article (PubMed ID: 8041378)
1. Botulinum toxin in the treatment of dystonic tics.
Jankovic J
Mov Disord; 1994 May; 9(3):347-9. PubMed ID: 8041378
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of botulinum toxin in severe Tourette syndrome with dystonic tics involving the neck.
Aguirregomozcorta M; Pagonabarraga J; Diaz-Manera J; Pascual-Sedano B; Gironell A; Kulisevsky J
Parkinsonism Relat Disord; 2008; 14(5):443-5. PubMed ID: 18337152
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome.
Scott BL; Jankovic J; Donovan DT
Mov Disord; 1996 Jul; 11(4):431-3. PubMed ID: 8813224
[TBL] [Abstract][Full Text] [Related]
4. Severe motor tics causing cervical myelopathy in Tourette's syndrome.
Krauss JK; Jankovic J
Mov Disord; 1996 Sep; 11(5):563-6. PubMed ID: 8866498
[TBL] [Abstract][Full Text] [Related]
5. Dystonic tics in patients with Tourette's syndrome.
Jankovic J; Stone L
Mov Disord; 1991; 6(3):248-52. PubMed ID: 1922130
[TBL] [Abstract][Full Text] [Related]
6. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
Mov Disord; 1987; 2(4):237-54. PubMed ID: 3504553
[TBL] [Abstract][Full Text] [Related]
7. Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A.
Porta M; Maggioni G; Ottaviani F; Schindler A
Neurol Sci; 2004 Feb; 24(6):420-3. PubMed ID: 14767691
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin A--injection for cervical dystonia.
Bhaumik S; Behari M
J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin in the treatment of tics.
Kwak CH; Hanna PA; Jankovic J
Arch Neurol; 2000 Aug; 57(8):1190-3. PubMed ID: 10927800
[TBL] [Abstract][Full Text] [Related]
10. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
[TBL] [Abstract][Full Text] [Related]
11. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
Sankhla C; Jankovic J; Duane D
Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
[TBL] [Abstract][Full Text] [Related]
12. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
[TBL] [Abstract][Full Text] [Related]
13. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
[TBL] [Abstract][Full Text] [Related]
14. Response to botulinum toxin F in seronegative botulinum toxin A--resistant patients.
Greene PE; Fahn S
Mov Disord; 1996 Mar; 11(2):181-4. PubMed ID: 8684389
[TBL] [Abstract][Full Text] [Related]
15. Treatment of various movement disorders with botulinum A toxin injection: an experience of 900 patients.
Poungvarin N; Devahastin V; Viriyavejakul A
J Med Assoc Thai; 1995 Jun; 78(6):281-8. PubMed ID: 7561552
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM
Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A in blepharospasm and hemifacial spasm.
Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK
J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509
[TBL] [Abstract][Full Text] [Related]
19. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
20. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
